行情

PRAH

PRAH

PRA Health
NASDAQ

实时行情|Nasdaq Last Sale

78.51
-1.36
-1.70%
盘后: 78.67 +0.16 +0.20% 16:11 03/27 EDT
开盘
77.05
昨收
79.87
最高
80.92
最低
74.25
成交量
47.61万
成交额
--
52周最高
113.10
52周最低
58.67
市值
49.90亿
市盈率(TTM)
21.25
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测PRAH价格均价为113.23,最高价位135.00,最低价为89.00。

EPS

PRAH 新闻

更多
  • Raleigh firm launches COVID-19 tracking app for employers, health care workers
  • American City Business Journals · 3天前
  • PRA Health Sciences expands remote clinical study support with its Mobile Health Platform during COVID-19 pandemic
  • GlobeNewswire · 5天前
  • Coronavirus activity roundup - healthcare
  • Seeking Alpha - Article · 5天前
  • PRA Health's New Program to Lend Support to Healthcare System
  • Zacks · 6天前

所属板块

生物技术和医学研究
-2.43%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

PRAH 简况

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.
展开

微牛提供PRA Health Sciences Inc(NASDAQ-PRAH)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PRAH股票新闻,以帮助您做出投资决策。